Abstract
The potential for synergistic collaboration to increase progress in the state of the science for ovarian cancer is provided by services and programs developed and supported by National Cancer Institute (NCI), the Gynecologic Oncology Group (GOG) and the Specialized Programs of Research Excellence (SPOREs). The capabilities span from drug discovery to phase III clinical trials, all of which are available for collaborative interaction with each other and with individual researchers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
